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ABSTRACT: X-ray diffraction analysis of (R,S)- and S-atenolol crystalline forms was performed. The crystals studied were grown
from evaporation of an ethanol/water solution. (R,S)-Atenolol crystallizes in the centrosymmetric space group C2/c, and S-atenolol
crystallizes in a noncentrosymmetric space group C2. There is one symmetry independent molecule in (R,S)-atenolol crystals and
two symmetry independent molecules in S-atenolol. However, due to disorder, two different molecular conformations were identified
in the (R,S)-atenolol, and three different conformations were isolated in S-atenolol. Flexibility of molecular segments of the carbon
chain is seen in conformational isomorphism and in the atomic position uncertainty. The molecular conformations given by X-ray
diffraction were fully relaxed at the HF/6-31G* level of theory. The optimized structure was used as reference in comparison with
molecular conformation in the solid state.
Introduction
Since bioavailability and properties related to formulation
depend on the crystalline structure, its knowledge is essential
in pharmaceutical technology.1-3 Single-crystal X-ray diffraction
is the most useful technique available for obtaining compre-
hensive information on the molecular and crystal structures. The
problem that has to be overcome is the preparation of single
crystals suitable for study by this technique.
A factor often associated with the difficulties in the crystal-
lization of organic compounds is the conformational diversity
in solution. Molecules of large size exhibit numerous confor-
mational possibilities giving rise to minuscule crystal size or
amorphous solid materials.4,5 Single-crystal growth is often a
true challenge combining science and art and even a little luck,
hence the lack of data about the structure of many organic
compounds.
This work concerns the study of the structure of atenolol,
4-[2′-hydroxy-3′-[(1-methylethyl)amino]propoxy]-benzeneaceta-
mide, a compound widely prescribed in medicine as a cardi-
oselective â1-adrenergic blocker. As a best-selling drug,6,7
atenolol has become the focus of active research. Nevertheless,
its crystal structure has not yet been reported, which is a serious
obstacle to understanding its properties from both the theoretical
and the practical point of view.
The atenolol molecule has a chiral center giving rise to R
and S enantiomers, which have different biological activities.8
This paper deals with the structure of the racemic and homo-
chiral forms, studied by X-ray diffraction and molecular
modeling.
Experimental Procedures
(R,S)-Atenolol purchased from Mikromol Gmbh was the original
substance used in this research. The product came with a quality control
certificate with a specification of 99.76 mol percent pure. The degree
of purity was based on NMR, HPLC, and acid-base titration tests.
S-(-)-Atenolol was supplied by Sigma-Aldrich as 99% pure. HPLC
did not reveal any impurity. The value found for [R] D25 was -16.2° (C
) 1 in 1 N HCl).
Single crystals of both compounds were obtained by slow evapora-
tion of the solvent from solutions of (R,S)-atenolol or S-atenolol in
ethanol/water. A 0.1 M solution of atenolol in 20:80 volume percent
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† Department of Chemistry.
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# CEMDRX, Department of Physics.
Figure 1. (a) Photomicrograph with polarized light of (R,S)-atenolol
crystals (50); (b) detail of crystal aggregates (200).
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ethanol/water was evaporated at 25 °C from a narrow neck conical
flask. The crystalline solid was dried at 40 °C and kept in a desiccator.
When the sample was examined by polarized light microscopy, optically
anisotropic laminate crystals were observed (Figure 1). Identical
crystalline habit is observed for both racemic and enantiomeric forms.
Diffraction measurements of (R,S)-atenolol were carried out by Cu
KR radiation using a Mach-3 diffractometer equipped with a conven-
tional detector. Data reduction was performed with HELENA.9 For
S-atenolol, a similar diffractometer was used, equipped with an area
detector. Data reduction was performed with Bruker SAINT.10 Lorenz
and polarization corrections were applied to both data sets. The
structures were solved with direct methods using the SHELXS-97
program11 and refined on F2’s by full-matrix least-squares with the
SHELXL-97 program.11 Anisotropic displacement parameters for non-
hydrogen atoms were applied with the exception of terminal C(13) and
C(14) for (R,S) and of those atoms in the disordered part of one of the
molecules for S-atenolol. Hydrogen atoms were placed at calculated
positions and refined with isotropic parameters as riding mobile atoms,
except for those of the disordered methyl groups, which were not
included in the refinement.
For (R,S)-atenolol the bond distances, C(12)-C(13), C(12)-C(14),
C(10)-C(11), and N(2)-C(11) were constrained to be 1.5, 1.5, 1.5,
and 1.3 Å, respectively, during the refinement.
Space groups were assigned using PLATON, and the systematic
absences were carefully checked, namely, the h01 reflections, confirm-
ing the assignment of C2 to the structure of S-atenolol.
The structure of the (R,S)- and S-atenolol, retaining the solid-state
conformations shown by X-ray, was fully optimized at HF/6-31G* level
of theory using the Gaussian 98 convergence criteria.12
Results and Discussion
X-ray Diffraction. The crystal data and details concerning
data collection and structure refinement are given in Table 1.
The ORTEPII13 drawings of (R,S) and S-atenolol are shown in
Figure 2.
(R,S)-Atenolol crystallizes in the centrosymmetric space group
C2/c. The molecular backbone consists of a head formed by
the acetamide group, a central part composed by the atoms from
C(2) to C(9), and a tail from the chiral C(10) to C(14). The
atoms of the first two parts are in a well-defined arrangement,
whereas some disorder is observed in the last one. The molecular
tail can adopt two structures, differing from one another in C(11)
position. In one of these conformations, (R,S)a, this carbon atom
is in the C(11a) position, and in the other, (R,S)b, it is in the
C(11b) position. The relative occurrence of these structures is
57% of (R,S)a to 43% of (R,S)b. Despite the C(11) positional
difference, a unique structure is shown by the isopropylamino
group. Each enantiomer statistically occupies an R and S
configuration.
Neglecting a small deviation of the C(9), all non-hydrogen
atoms of the central molecular segment are in the plane defined
by the aromatic ring. C(1), O(1), and N(1) of the amide group
are in another plane, making an angle of 86.1° with the former.
The angles of the bonds centered at N(1) are close to 120°, and
the sum of the angles with C(1) as common vertex is also 360°,
although small differences are observed among them.
The molecules are aligned along the a axis. They are oriented
head to head, and the heads are linked by hydrogen bonds along
both the a- and c-axis, forming a ladder as seen in Figure 3.
Each hydrogen atom of the acetamide group is shared with an
oxygen atom of a symmetry-related acetamide group, delineating
rings of eight atoms, with graph-designator R2,2(8). H(3) is
Table 1. Crystal Data and Structure Refinement Parameters for (R,S)-Atenolol and S-Atenolol
(R,S)-atenolol S-atenolol
empirical formula C14 H22 N2 O3 C14 H22 N2 O3
formula weight 266.34 266.34
temperature/K 293(2) 293(2)
wavelength/Å 1.54180 1.54180
crystal system monoclinic monoclinic
space group C2/c C2
a/Å 55.83(3) 54.43(3)
b/Å 5.559(3) 5.712(3)
c/Å 9.734(2) 9.676(2)
â/° 100.042(6) 99.510(6)
volume/Å3 2975(2) 2967(2)
Z 8 8
calculated density/g cm-3 1.189 1.192
absorption coefficient/mm-1 0.681 0.682
FOOO 1152 1152
crystal size/mm 0.50  0.37  0.07 0.42  0.36  0.07
ı range for data collection/˚ 3.2-72.6 4.6-73.3
index ranges -66 < h < 67, -6 < k < 6, -12 < l < 12 -66 < h < 60, -7 < k < 7, -11 < l < 11
reflections collected/unique 6262/2919 [R(int) ) 0.052] 11689/5474 [R(int) ) 0.044]
completeness to ımax 99.0% 97.3%
refinement method full-matrix least-squares on F2 full-matrix least-squares on F2
data/restraints/parameters 2919/2/174 5474/1/338
goodness-of-fit on F2 1.803 1.055
final R indices [I > 2ó(I)] R1 ) 0.1296 wR2 ) 0.3867 R1 ) 0.0746 wR2 ) 0.1891
R indices (all data) R1 ) 0.1505 wR2 ) 0.4145 R1 ) 0.0990 wR2 ) 0.2097
largest diff peak and hole /e Å-3 0.78 and -0.84 0.68 and -0.39
Figure 2. (R,S)- and S-atenolol ORTEPII drawing. The ellipsoids are
drawn at the 30% probability level for clarity reasons.
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donated by O(3) to N(2) of a translated molecule (along b),
thus linking the molecules along the short axis and delineating
a ladder structure, typical of many primary amides with the
alternating R2,2(8) and R4,2(8) hydrogen-bonding patterns. The
values of atomic distances, bond angles, and torsion angles in
the structure of (R,S)-atenolol are presented in Table 2, and the
characteristic parameters of the classical hydrogen bonds are
given in Table 3.
The ð electron cloud of the aromatic phenyl ring also acts as
an acceptor in this structure, joining the molecules along the
c-axis. The donor C(9)-ring centroid distance is 3.778(4) Å
with a bond angle of 147.5° and the deviation of the shared
hydrogen 9.4° from the ring plane perpendicular. These values
are within the geometrical requirements for an effective
bond.14-16 Such an interaction can be considered as a weak
hydrogen bond, provided the donor is an acidic group.15 The
Mulliken charge distribution suggest a slightly higher acidic
character of C(9)-H than that manifested by the other C-H
groups, an argument in favor of the contribution of this
interaction in (R,S)-atenolol structure stabilization.17-19
A further participation of ð electrons of the phenyl group
may occur by ðâââð interactions. According to Sanders et al.,20
these are really an interaction between the ð electrons of one
group with ó electrons of the other aromatic ring. The average
centroid distance between neighbors is 5.55 Å, and the vector
from the centroid of one of the molecules to the centroid of the
other makes an angle of 29.7° with the normal to the plane of
the former.
S-Atenolol crystallizes in a noncentrossymetric space group
C2 with two symmetry-independent molecules. One of these is
fully ordered, and the other shows two alternative positions from
the chiral center, C(10), onward (Figure 2). Three molecular
conformations are observed in the S-atenolol: Sa that corre-
sponds to the fully ordered structure, and Sb and Sc, which
correspond to the molecules linked to the former. The ratio of
Sb to Sc is 1:0.6. Bearing in mind the structural identity of Sb
and Sc from the molecular head to C(10), distinct atom
numbering was used only in the molecular tails.
The head and central parts of the S molecules are similar to
those of (R,S)a or (R,S)b. The differences between the conforma-
tions exhibited by the crystals of the racemic and enantiomeric
forms lie in the molecular tail structure. These features can be
seen in Figure 4, in which the three molecular conformations
of the S-atenolol crystal are depicted.
The molecules are assembled in the same way in either S- or
(R,S)-atenolol. The same eight-membered ring elements are seen
Figure 3. Packing diagram of (R,S)- and S-atenolol projected along
the b-axis. Intermolecular hydrogen bonds as dashed lines.
Table 2. Bond Lengths, Bond Angles, and Dihedral Angles for the Molecular Conformation in the Solid State and after Optimization at the
HF/6-31G* Level of Theory
(R,S)a (R,S)b Sa Sb Sc
crystal relaxed crystal relaxed crystal relaxed crystal relaxed crystal relaxed
Bond Lengths/Å
C(1)-O(1) 1.238(2) 1.200 1.238(2) 1.199 1.251(3) 1.200 1.253(3) 1.199 1.253(3) 1.199
C(1)-N(1) 1.315(3) 1.351 1.315(3) 1.353 1.324(4) 1.351 1.344(4) 1.351 1.344(4) 1.351
N(2)-C(11) 1.439(6) 1.457 1.491(7) 1.453 1.494(4) 1.453 1.637(10) 1.446 1.204(12) 1.448
N(2)-C(12) 1.377(8) 1.460 1.377(8) 1.463 1.506(4) 1.461 1.633(12) 1.457 1.592(15) 1.457
Bond Angles/°
O(1)-C(1)-N(1) 121.49(19) 122.5 121.49(19) 122.5 122.9(3) 122.5 121.6(2) 122.5 121.6(2) 122.5
C(2)-C(1)-O(1) 121.04(18) 120.3 121.04(18) 120.8 119.6(2) 120.2 120.7(2) 120.3 120.7(2) 120.2
C(2)-C(1)-N(1) 117.47(16) 117.2 117.47(16) 116.6 117.5(2) 117.2 117.7(2) 117.2 117.7(2) 117.3
C(11)-N(2)-C(12) 122.4(5) 116.9 100.7(5) 117.8 114.6(2) 116.8 128.3(6) 122.4 108.6(9) 115.9
Torsion Angles/°
N(1)-C(1)-C(2)-C(3) -141.2(2) -18.8 -141.2(2) -18.8 135.0(3) 16.9 -142.1(2) -19.9 -142.1(2) -17.4
O(1)-C(1)-C(2)-C(3) 39.4(3) 163.9 39.4(3) 163.9 -44.7(4) -165.6 38.7(4) 162.9 38.7(4) 165.2
C(1)-C(2)-C(3)-C(4) -102.7(2) -85.2 -102.7(2) -85.2 104.8(3) 85.9 -105.3(3) -84.7 -105.3(3) -85.7
C(7)-C(6)-O(2)-C(9) 173.6(2) 179.9 173.6(2) -179.0 -171.0(2) -179.9 -178.2(3) 179.5 -178.2(3) -179.8
C(6)-O(2)-C(9)-C(10) -171.4(2) -179.3 -171.4(2) 177.1 168.7(2) -179.2 179.5(3) 177.2 179.5(3) 177.8
O(2)-C(9)-C(10)-O(3) -69.4(4) -59.0 -69.4(4) -63.9 69.8(3) 59.2 -60.1(3) -63.3 -60.1(3) -59.8
O(2)-C(9)-C(10)-C(11) 157.81(18) -177.7 97.0(2) 60.9 -169.4(2) 178.0 62.8(3) 59.9 85.7(5) 65.4
C(9)-C(10)-C(11)-N(2) -75.9(4) -61.6 72.6(4) 55.3 77.5(3) 63.4 79.5(4) 55.4 -174.3(7) 173.9
O(3)-C(10)-C(11)-N(2) 151.5(4) 177.5 -123.5(5) -180.0 -159.9(2) -175.5 -156.7(4) 179.0 -35.3(10) -61.5
C(10)-C(11)-N(2)-C(12) -101.5(6) -110.5 156.9(4) 152.9 70.0(3) 89.7 151.0(6) 84.0 147.4(9) 170.3
Table 3. Interatomic Distances and Angles Related to
Intermolecular Hydrogen Bonding
D-HâââA
DâââA
(Å)
HâââA
(Å)
D-HâââA
(deg) symmetry
(R,S)-atenolol
N(1)-H(1A)âââO(1) 2.900(3) 2.04 173.9 1/2 - x, 3/2 - y,
1 - z
N(1)-H(1B)âââO(1) 2.884(3) 2.06 161.5 x, 1 - y, -1/2 + z
O(3A)-H(3)âââN(2A) 2.983(7) 2.49 119.7 x, 1 + y, z
S-atenolol
N(1A)-H(1A)âââO(1B,C) 2.932(3) 2.08 172.6
N(1A)-H(1B)âââO(1B,C) 2.857(3) 2.05 157.3 1/2 - x, 1/2 + y,
1 - z
N(2A)-H(2)âââO(3A) 2.776(3) 2.20 123.7 x, 1 + y, z
N(1B,C)-H(1A)âââO(1A) 2.895(3) 2.04 175.1
N(1B,C)-H(1B)âââO(1A) 2.851(3) 2.05 154.7 1/2 - x, -1/2 + y,
-z
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between the molecular heads. In S-atenolol hydrogen bonds
between the acetamide groups now join symmetry-independent
molecules. The molecules are again linked along the b-axis but
this time with the N(2) and O(3) reversing the acceptor-donor
roles (Figure 3). The geometrical data related to the conforma-
tions of S-atenolol are given in Table 2, and the values used in
the assignment of hydrogen bonds are presented in Table 3.
Besides the hydrogen bonds listed in Table 3, as in (R,S)-
atenolol, C(9)-Hâââð and ðâââð bonds also contribute to
intermolecular interactions in S-atenolol. In fact, the carbon-
ring centroid distance is 3.765(4) Å in Sa, and 3.568(4) Å in Sb
or Sc. The values of the bond angle are 151.1° in Sa, and 144.9°
in Sb or Sc. The deviations of the shared hydrogen to the ring
plane normal are 8.9° in Sa, and 7.7° in Sb or Sc. Ring centroid
distances between interacting ðâââð molecules are 5.578(3) Å
with a deviation of centroid-centroid line from ring plane
normal of about 29.8°.
A general feature shown by racemic and enantiomeric single
crystals is the similarity of the structure of both forms with very
similar cell constants. Three types of racemic modifications are
usually considered to describe the systems formed by opposite
enantiomeric forms:21 racemic compound (single solid phase
of both enantiomers), racemic mixture or conglomerate (crystal
mixture of pure enantiomers), and pseudoracemate (solid
solution of the enantiomers). About 90% of the organic chiral
compounds give rise to racemic compounds and 5-10% to
racemic mixtures. The occurrence of pseudoracemate is rela-
tively rare.22 This structure was described for DL-carvone,23
camphor and some derivatives,24 and tazofelone.25
Differential scanning calorimetry, powder X-ray diffraction,
13C NMR studies26 and differential scanning calorimetry, and
powder X-ray diffraction FTIR and Raman27 led to the conclu-
sion that (R,S)-atenolol is a solid solution of the enantiomeric
forms. These conclusions are in agreement with those drawn
from the present study.
A second point that deserves mention is the diversity of
molecular conformations taken by the C(10) to C(14) molecular
fragment. Besides a distinct structure shown by the conformers,
further uncertainties in the atomic position are also observed in
particular in (R,S)-atenolol. A rather similar structural pattern
was recently described for tazofelone.25 (R,S)-Atenolol and
S-atenolol are examples of conformational isomorphism, that
is, single crystal with different conformers.3,28,29
Optimization of the Structure of the Atenolol Molecule.
The structure of the atenolol molecules retaining the conforma-
tion of the solid state were freed to relax at the HF/6-31G*
level of theory. The resulting structure corresponds to the
molecule free from intermolecular interactions in a minimum
potential energy surface close to the solid-state energy confor-
mation. The values of the geometrical parameters of the
equilibrium conformations obtained are given in Table 2. This
table allows the comparison of the atomic distances and bond
angles of the conformations shown by X-ray, before and after
being optimized.
A significant difference between the molecular conformation
in the solid and in the free state is exhibited by the amide group.
As the molecules are freed from the intermolecular forces, a
118°-122° rotation around the C(1)-C(2) bond takes place,
and the amide group acquires a configuration that enables the
interaction of one of the N(1)-H with the phenyl group. The
average atomic distances of N(1) and H(1B) from the phenyl
centroid are 3.80(0) Å and 3.10(1) Å for the five molecular
types considered, and the N(1)-H(1B)-phenyl centroid angle
is 128.9(1)°, values well within the criteria assigned to the
existence of a hydrogen bond between N-H as the donor group
and the ð electrons of the phenyl ring as acceptor.14,16,30 This
type of interaction is quite commonly invoked accounting to
the 3D structure stabilization of protein and other polymeric
organic molecules.14,15 The conformation adopted by the atenolol
molecules in the free state is illustrated in Figure 5.
The hydrogen bond involving the amide group enhances the
sp2 hybridization of C(1) and N(1). Indeed, as in the solid state,
the sum of the angles centered at these two atoms in the
optimized structure is 360°, but the deviation of each angle from
120° and of one from another is higher in the latter than in the
former. Furthermore, the presence of the hydrogen bonds
shortens the C(1)-N(1) bond and simultaneously lengthens
C(1)-O(1). These effects are also observed in small molecules
such as acetamide.31,32
Knowledge of the energy barrier between the optimized
structures Sb and Sc is important to answer the question about
the possibility of transforming one into the other. The calculation
was performed at the same level of theory as that used in the
structure optimization, and the transition state structure was
obtained by the qst3 method, which gives rise to an imaginary
vibration frequency. The transition states of the two structures
differ in the C(9)-C(10)-C(11)-N(2) dihedral, whose value
is 112.4°. The barrier level corresponding to the transformation
of Sb into Sc is 11.4 kJ/mol, and 37.4 kJ/mol is the energy
required for the inverse process. In conclusion, Sb and Sc both
can be considered stable structural conformations of S-atenolol.
Conclusion
This work provides, for the first time, data on the crystal
structure of atenolol. X-ray diffraction of single crystals
combined with computational calculations of the molecule,
retaining the conformation in the solid state, allow a detailed
description of the spatial arrangement of the atoms in the
molecules and of these in the crystal lattice.
The hydrogen-bonding network set up by the amide and
phenyl group originates quite an ordered molecular structureFigure 4. Molecular conformations exhibited by S-atenolol.
Figure 5. Pattern of the optimized Sa molecular structure.
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from C(1) to C(9), common to the crystalline form in either
the racemic or the homochiral form. The rest of the molecule
adopts several conformations: some have close energy values,
indiscriminated by X-rays, and others are distinct structures.
Both the racemic atenolol and the S-atenolol crystals display
distinct molecular conformations from C(9) to the molecule
terminal isopropyl. All the structures to some extent exhibit a
certain disordered state.
The conformational isomorphism in molecules like these we
are dealing with occurs when molecular segments are flexible
enough and packing allows a different structure. It should thus
be expected to be quite a common phenomenon in solid organic
chemistry in molecules with a medium or large backbone.
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